Edwards Lifesciences Corp

مادة اعلانية

Latest Update: 16 Nov 2024 00:59 Abu Dhabi Time.

Market Status: Closed

67.78

USD

1.620

2.45%

Open

65.71

Prev Close

67.76

PX_VOLUME

MARKET CAP (M)

54,384.65

DAY RANGE

65.31 - 67.83

52 WEEKS

58.93 - 96.12

Stock Statistics

Yearly Change

0.43%

Listed Shares (Million)

654.30

Earnings Multiple

9.82

Average 30-day trading volume

4,531,425.10

Price-to-book ratio

4.19

Earnings Per Share

2.31

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue		1,354.40	1,385.90	1,598.20	1,534.10	1,243.40	1,295.50	1,459.60
Gross Profit		1,091.50	1,100.60	1,212.60	1,177.20	992.80	1,038.60	1,130.10
Operating Income		394.30	377.20	437.70	427.20	368.10	384.50	432.60
Net Income		362.10	366.40	351.00	369.70	334.90	254.20	340.50
Profit Margin		26.74	26.44	21.96	24.10	26.93	19.62	23.33

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		6,004.80	5,382.40	5,232.50	4,386.30
Gross Profit		4,625.00	4,302.00	3,983.60	3,305.70
Operating Income		1,728.60	1,789.20	1,586.80	1,316.60
Net Income		1,399.40	1,521.90	1,503.10	823.40
Profit Margin		23.30	28.28	28.73	18.77

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets		12,971.20	10,099.30	9,736.30	9,363.20	9,370.80	9,004.00	8,651.20
Total Liabilities		3,359.80	2,594.70	2,549.90	2,643.80	2,643.70	2,557.50	2,589.20
Total Equity		9,611.40	7,504.60	7,186.40	6,719.40	6,727.10	6,446.50	6,062.00

Cash Flows Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Cash From Operating Activities		351.80	371.50	-53.50	136.60	411.50	33.60	314.10
Cash From Investing Activities		2,701.70	124.80	63.10	14.10	89.00	70.20	0.50
Cash From Financing Activities		-976.70	-96.60	61.70	-413.20	-143.30	52.10	-206.60
Net Change in Cash		2,025.30	429.10	81.00	-265.90	366.40	171.10	103.80

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		895.80	1,218.20	1,732.10	1,054.30
Cash From Investing Activities		173.80	252.30	-1,722.50	-531.10
Cash From Financing Activities		-711.00	-1,584.50	-356.30	-486.90
Net Change in Cash		375.40	-94.80	-332.80	15.80

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

Edwards Lifesciences Corp

إدواردز لايفسيانسز كورب